Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Former Edmonton City Manager Joins Danchilla Consulting
-
Dickey’s Barbecue Hires New Director of R & D: Chef Matt Burton
-
Dickey’s Barbecue Hires New Director of R & D: Chef Matt Burton
-
Pulse Oil Announces Operational Results, EOR Progress Update, and Provides Results of Independent Reserve Evaluation
-
Restaurants Canada’s response to Federal Budget 2024
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sonder
-
Eureka Shipping Announces Construction of New Cutting-Edge Cement Carrier for Great Lakes Trade
-
Eureka Shipping Announces Construction of New Cutting-Edge Cement Carrier for Great Lakes Trade
-
Beyond, Inc. Scheduled to Release First Quarter Financial Results on May 6, with a Premarket Call on May 7
-
Silver Mountain Announces $7.5 Million Public Offering
-
PERI INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Perion Network Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Genco Shipping & Trading Limited Files Definitive Proxy Materials and Mails Letter to Shareholders
-
Genco Shipping & Trading Limited Files Definitive Proxy Materials and Mails Letter to Shareholders
-
Xcel Brands, Inc. Announces Fourth Quarter and Fiscal Year 2023 Results
-
Atico Reports Consolidated Financial Results for 2023
-
XWELL, Inc. Reports Fiscal Year 2023 Results
-
Powell Industries Announces Date and Conference Call for Fiscal 2024 Second Quarter Results
-
Mercer International Inc. Announces Conference Call for First Quarter 2024 Results
-
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
-
Globus Medical Schedules First Quarter Earnings Release and Conference Call
-
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
-
CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024
-
Weatherford Releases 2023 Digital Annual Update
-
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
-
Sezzle to Participate in Upcoming Investor Conferences
-
Twin Disc Announces Details of Fiscal 2024 Third Quarter Earnings Release, Webcast, and Conference Call
-
Enterprise Bancorp, Inc. Announces Quarterly Dividend
-
Mercury Systems to Report Third Quarter Fiscal Year 2024 Financial Results on May 7, 2024
-
AMD to Report Fiscal First Quarter 2024 Financial Results
-
K92 Mining 2024 First Quarter Financial Results Conference Call Details
-
NetLogistik Partners With Vuzix Wholly Owned Subsidiary Moviynt to Offer Mobility Solutions for the Warehouse
-
Oil-Dri to Acquire Ultra Pet in Strategic Move to Compete in Rapidly Growing Crystal Cat Litter Market
-
SiriusPoint Announces Date for First Quarter 2024 Earnings Release
-
Angi Inc. to Announce Q1 2024 Earnings on May 7th and Host Earnings Conference Call on May 8th
-
Rumble Announces Timing of First Quarter 2024 Earnings Release and Conference Call
-
Angi Inc. to Announce Q1 2024 Earnings on May 7th and Host Earnings Conference Call on May 8th
-
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program
-
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
-
iLearningEngines, Inc. Becomes Publicly Traded Company After Completing Business Combination With Arrowroot Acquisition Corp., Will Commence Trading on Nasdaq Under Ticker Symbol “AILE”
-
New York Mortgage Trust 2024 First Quarter Conference Call Scheduled for Thursday, May 2, 2024
-
Vespra Hills Golf Club Joins the ClubLink Family of Managed Clubs
-
Flywire to Announce First Quarter 2024 Results on May 7, 2024
-
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
-
Open Lending to Announce First Quarter 2024 Results on May 7, 2024
-
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
-
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
-
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
-
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Kamari Pharma Announces Abstracts Accepted for Presentation at the 81st Annual Meeting of the Society for Investigative Dermatology


